References
- World Health Organization (WHO) Coronavirus disease (COVID-19) Situation Report – 199 [cited 6 Aug 2020]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/.
- Tang T, Bidon M, Jaimes JA, et al. Coronavirus membrane fusion mechanism offers a potential target for antiviral development. Antivir Res. 2020;178:104792. DOI:10.1016/j.antiviral.2020.104792.
- Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426(6965):450–454. DOI:10.1038/nature02145.
- Li F, Li W, Farzan M, et al. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science. 2005;309(5742):1864–1868. DOI:10.1126/science.1116480.
- Walls AC, Park YJ, Tortorici MA, et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181(2):281–292. DOI:10.1016/j.cell.2020.02.058.
- Shang J, Wan Y, Luo C, et al. Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci USA. 2020;117(21):11727–11734. DOI:10.1073/pnas.2003138117.
- Shang J, Ye G, Shi K, et al. Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020;581(7807):221–224. DOI:10.1038/s41586-020-2179-y.
- Lan J, Ge J, Yu J, et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020;581(7807):215–220. DOI:10.1038/s41586-020-2180-5.
- Du L, He Y, Zhou Y, et al. The spike protein of SARS-CoV – a target for vaccine and therapeutic development. Nat Rev Microbiol. 2009;7(3):226–236. DOI:10.1038/nrmicro2090.
- Wu F, Zhao S, Yu B, et al. Author correction: a new coronavirus associated with human respiratory disease in China. Nature. 2020;580(7803):E7. DOI:10.1038/s41586-020-2202-3.
- Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273. DOI:10.1038/s41586-020-2012-7.
- Andersen KG, Rambaut A, Lipkin WI, et al. The proximal origin of SARS-CoV-2. Nat Med. 2020;26(4):450–452. DOI:10.1038/s41591-020-0820-9.
- Korber B, Fischer WM, Gnanakaran S, et al. Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19. Cell. 2020;182:812–827. DOI:10.1016/j.cell.2020.06.043.
- Li Q, Wu J, Nie J, et al. The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity. Cell. 2020;182:1–11. DOI:10.1016/j.cell.2020.07.012.
- Nextstrain. Available at: https://nextstrain.org/ncov.
- Global Initiative on Sharing All Influenza Data (GISAID). Available at: https://www.gisaid.org/.
- Cai Y, Zhang J, Xiao T, et al. Distinct conformational states of SARS-CoV-2 spike protein. Science. 2020: eabd4251. DOI:10.1126/science.abd4251.
- Xia S, Yan L, Xu W, et al. A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike. Sci Adv. 2019;5(4):eaav4580. DOI:10.1126/sciadv.aav4580.
- Cheng MH, Zhang S, Porritt RA, et al. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation. PNAS. 2020;117:25254–25262. DOI:10.1073/pnas.2010722117.
- Vishnubhotla R, Vankadari N, Ketavarapu V, et al. Genetic variants in TMPRSS2 and Structure of SARS-CoV-2 spike glycoprotein and TMPRSS2 complex. bioRxiv. 2020. DOI:10.1101/2020.06.30.179663
- Quick J, Grubaugh ND, Pullan ST, et al. Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples. Nat Protoc. 2017;12(6):1261–1276. DOI:10.1038/nprot.2017.066.
- Borges V, Pinheiro M, Pechirra P, et al. INSaFLU: an automated open web-based bioinformatics suite “from-reads” for influenza whole-genome-sequencing-based surveillance. Genome Med. 2018;10(1):46. DOI:10.1186/s13073-018-0555-0.
- Hadfield J, Megill C, Bell SM, et al. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics. 2018;34(23):4121–4123. DOI:10.1093/bioinformatics/bty407.
- Argimón S, Abudahab K, Goater RJE, et al. Microreact: visualizing and sharing data for genomic epidemiology and phylogeography. Microb Genom. 2016;2(11):e000093. DOI:10.1099/mgen.0.000093.
- Alm E, Broberg E K, Connor T, et al. Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020. Euro Surveill. 2020;25:32. DOI:10.2807/1560-7917.ES.2020.25.32.2001410.
- Rueca M, Bartolini B, Gruber CEM, et al. Compartmentalized replication of SARS-Cov-2 in upper vs. lower respiratory tract assessed by whole genome quasispecies analysis. Microorganisms. 2030;8(9):1302.
- Gudbjartsson DF, Helgason A, Jonsson H, et al. Spread of SARS-CoV-2 in the Icelandic population. N Engl J Med. 2020;382(24):2302–2315. DOI:10.1056/NEJMoa2006100.
- Lorenzo-Redondo R, Nam HH, Roberts SC, et al. A unique clade of SARS-CoV-2 viruses is associated with lower viral loads in patient upper airways. medRxiv. 2020. DOI:10.1101/2020.05.19.20107144.
- Wagner 2020. https://github.com/blab/ncov-D614G.
- COVID-19 pandemic lockdown in Italy. [cited 31 Aug 2020]. Available from: https://en.wikipedia.org/wiki/COVID-19_pandemic_lockdown_in_Italy.